Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2017, Article ID 9762803, 3 pages
https://doi.org/10.1155/2017/9762803
Case Report

Paralytic Ileus Secondary to Methamphetamine Abuse: A Rare Case

1School of Clinical Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2 0SP, UK
2Department of General Surgery, Bedford Hospital NHS Trust, Kempston Road, Bedford MK42 9DJ, UK

Correspondence should be addressed to Mark Aidan McKelvie; moc.liamg@eivlekcmkram

Received 3 June 2017; Accepted 7 August 2017; Published 31 August 2017

Academic Editor: Gabriel Sandblom

Copyright © 2017 Mark Aidan McKelvie and Yuksel Gercek. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Kish, “Pharmacologic mechanisms of crystal meth,” Canadian Medical Association Journal, vol. 178, no. 13, pp. 1679–1682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Deborah, “Drug Misuse: Findings from the 2014/15 Crime Survey for England and Wales,” Second edition, 2016, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/462885/drug-misuse-1415.pdf.
  3. Center for Behavioral Health Statistics and Quality, “2015 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration,” 2016, Rockville, MD, https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.pdf.
  4. R. B. Rothman and M. H. Baumann, “Monoamine transporters and psychostimulant drugs,” European Journal of Pharmacology, vol. 479, no. 1-3, pp. 23–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Neiman, H. M. Haapaniemi, and M. Hillbom, “Neurological complications of drug abuse: pathophysiological mechanisms,” European Journal of Neurology, vol. 7, no. 6, pp. 595–606, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. F. Bowyer, M. Thomas, L. C. Schmued, and S. F. Ali, “Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures, and the blood-brain barrier,” Annals of the New York Academy of Sciences, vol. 1139, pp. 127–139, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. J. Rhee, T. E. Albertson, and J. C. Douglas, “Choreoathetoid disorder associated with amphetamine-like drugs,” American Journal of Emergency Medicine, vol. 6, no. 2, pp. 131–133, 1988. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Watts and L. McCollester, “Methamphetamine-induced myocardial infarction with elevated troponin I,” The American Journal of Emergency Medicine, vol. 24, no. 1, pp. 132–134, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. G. G. Davis and C. I. Swalwell, “Acute aortic dissections and ruptured berry aneurysms associated with methamphetamine abuse,” Journal of Forensic Sciences, vol. 39, no. 6, pp. 1481–1485, 1994. View at Google Scholar · View at Scopus
  10. D. S. Goldstein, J. Nurnberger Jr., S. Simmons, E. S. Gershon, R. Polinsky, and H. R. Keiser, “Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man,” Life Sciences, vol. 32, no. 10, pp. 1057–1063, 1983. View at Publisher · View at Google Scholar · View at Scopus
  11. M. W. Dünser and W. R. Hasibeder, “Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress,” Journal of Intensive Care Medicine, vol. 24, no. 5, pp. 293–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-W. Seo, S. M. Jones, T. A. Hostetter, J. J. Iliff, and G. A. West, “Methamphetamine induces the release of endothelin,” Journal of Neuroscience Research, vol. 94, no. 2, pp. 170–178, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. T. D. Johnson and M. M. Berenson, “Methamphetamine-induced ischemic colitis,” Journal of Clinical Gastroenterology, vol. 13, no. 6, pp. 687–689, 1991. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Prendergast, A. H. Hassanein, V. Bansal, and L. Kobayashi, “Shock with intestinal ischemia: A rare complication of methamphetamine use,” American Surgeon, vol. 80, no. 1, pp. 101-102, 2014. View at Google Scholar · View at Scopus
  15. T. L. Carlson, T. P. Plackett, R. A. Gagliano Jr., and R. R. Smith, “Methamphetamine-induced paralytic ileus,” Hawai’i Journal of Medicine & Public Health, vol. 71, no. 2, pp. 44-45, 2012. View at Google Scholar · View at Scopus
  16. A. Dive, F. Foret, J. Jamart, P. Bulpa, and E. Installé, “Effect of dopamine on gastrointestinal motility during critical illness,” Intensive Care Medicine, vol. 26, no. 7, pp. 901–907, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. M. G. Zizzo, F. Mulè, M. Mastropaolo, and R. Serio, “D1 receptors play a major role in the dopamine modulation of mouse ileum contractility,” Pharmacological Research, vol. 61, no. 5, pp. 371–378, 2010. View at Publisher · View at Google Scholar · View at Scopus